The clinical challenges of managing type 2 diabetes and the potential of GLP-1-based therapies.
Zinman
Bernard
B
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018450:Disease Progression; D052216:Glucagon-Like Peptide 1 / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D054795:Incretins / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D054795:Incretins; D052216:Glucagon-Like Peptide 1